Newborn babies to be screened for life-threatening metabolic disorder

Newborn babies are to be routinely screened and treated earlier on the NHS for a rare life-threatening metabolic disorder that can result in the need for a liver transplant.

(c) Omar Lopez/Unsplash

(c) Omar Lopez/Unsplash

Hereditary Tyrosinaemia Type 1 (HT1), which is a rare, genetically inherited, disorder has been added to the NHS Newborn Blood Spot Screening Programme in England, following a recommendation by the UK National Screening Committee.

The condition will now be screened for in the blood test babies get on the fifth day after they are born, taken from the heel.

Dr Harrison Carter, NHS director of vaccination and screening, said: ‘Being able to screen for tyrosinaemia will help give hundreds of thousands of families extra reassurance and peace of mind – and while rare genetic conditions will be ruled out in most cases, for those families affected it means treatment and care can begin straight away, to improve their baby's chances of leading a healthy life.

‘This is a really vital step forward in care for newborn babies and will be important news for families who might be at risk of potentially life-threatening hereditary genetic conditions.'

NHS ConfedExpo: Murray offers 'not a change of course but a change of gear'

NHS ConfedExpo: Murray offers 'not a change of course but a change of gear'

By Lee Peart 11 June 2026

Health and social care secretary James Murray ‘offered not a change of course but a change of gear’ to healthcare leaders today.

Call for evidence on Cross-Government mental health strategy

By Lee Peart 18 May 2026

A call for evidence has been launched on a new cross-Government mental health strategy.

'Life-changing' therapies to be routinely available on NHS

By Lee Peart 14 May 2026

‘Life-changing’ muscle-wasting condition spinal muscular atrophy (SMA) therapies are to be routinely available to children on the NHS.


Popular articles by Lee Peart